E N D
1. The Immune Response to Tumors MCDB 4300
Rachel McMahan
6. Evidence for immune surveillance Inflammatory responses (lymphocytes, macrophages, NK cells) around and within solid tumors
Tumor reactive T cells can be isolated from tumor bearing animals and human patients
14. Cancer Immunoediting Elimination
Initiation of the antitumor immune response by cells of the innate immune system (macrophages, NK cells).
Antigens are liberated and the adaptive response is activated. T cells infiltrate.
Equilibrium
Escape
15. Cancer Immunoediting Elimination
Equilibrium
Lymphocytes infiltrate tumor, but do not fully extinguish it.
Small numbers of tumor cells remain
Can last up to 20 years.
Escape
17. Cancer Immunoediting Elimination
Equilibrium
Escape
Tumors have high genomic instability.
Tumors select for mutations that allow for evasion of the immune response.
19. Experimental immunotherapy for cancer Non-specific approaches
Polyclonal activation with cytokines
Introduction of co-stimulatory molecules or cytokines into tumor
Antigen-specific approaches
Tumor-specific antibodies
Vaccination with tumor antigens
Administration of expanded tumor-specific T cells back into patients.
23. Vaccination with tumor antigens